Fluence Energy Just Week Sparks AI Power Stocks Rally
Fluence Energy surged nearly 100% in a week on big contract wins and a growing backlog. A quartet of AI-exposed energ...
World Stock Indices Ranking
This section ranks key world stock indices and explains the metrics behind rankings, helping readers compare market breadth.
22,503 articles
Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Is Broadcom After Latest Earnings a Buy Right Now?
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...
Adobe Down 2026: Should Investors Switch to Alphabet?
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
Covered Calls Yield on the Magnificent Seven: Early Signals
Traders weigh covered calls on mega-cap tech as volatility stays elevated. This article explains how much yield could...
Duolingo Zeta Global: Which Tech Stock Is Best in 2026
Two software leaders battle for your 2026 portfolio: Duolingo and Zeta Global. This guide compares business models, g...
Cineverse (CNVS) 2026 Earnings: A Practical Investor Guide
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
Meta Stock Rises on the Misunderstood Truth About Demand
Meta Platforms rides a pivotal thesis: AI compute demand is real, scarce, and driving a company-wide pivot to data in...
Live: Will IonQ (IONQ) See Big Move After Earnings Results
IonQ posted quarterly results that beat expectations, triggering a notable after-hours rally. Analysts warn the stock...
Delta Lines Price Prediction Sparks 50% Upside in 2026
A veteran Wall Street analyst sees Delta Air Lines climbing roughly 50% in 2026, backed by fuel-efficiency gains and ...
Applied Optoelectronics Rises as NVIDIA’s AI Demand Expands
Applied Optoelectronics shares climbed after a strong quarterly showing and renewed appetite for laser transceivers f...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status